California drug testing
This article was originally published in The Tan Sheet
Reacting to rumors of excessive steroid use in professional baseball, California Assembly Arts, Entertainment, Sports, Tourism & Internet Media Committee approves SB 1738 by 11-0 vote June 26. Legislation, introduced Feb. 21 by Sen. Don Perata (D), would require professional athletic organizations that earn $1 bil. per year and hold sporting events in California to establish drug testing policies, test each athlete "at least once annually for the presence of any performance-enhancing substance," and penalize athletes who test positive for banned substances. State Athletic Commission would enforce testing requirements. SB 1738, which faces no opposition, moves to Appropriations Committee...
You may also be interested in...
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.